News
Swiss pharmaceuticals company Roche announces $50 billion investment in US over next 5 years
The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing facilities in places including Massachusetts, California, Indiana, and Pennsylvania.
The U.S. Food and Drug Administration (FDA) has approved Ferring Pharmaceuticals’ drug product manufacturing hub in Parsippany, NJ.
Ahead of its scheduled opening later this year, the massive Fujifilm Diosynth Biotechnologies manufacturing plant in Holly Springs has added a new customer in a lucrative deal. On Tuesday, Fujifilm ...
Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...
and we have a pharmaceutical division. Johnson &, Johnson has about 120,000 employees, 140 manufacturing plants and we have a total annual revenue of $65 billion.The pharmaceutical group is ...
INDIANAPOLIS — Roche, a Swiss biotechnology company whose U.S. headquarters is in Indianapolis, has announced its intention ...
President Donald Trump said Tuesday that pharmaceutical imports will soon be hit with “major” tariffs as part of his efforts ...
With threats of tariffs hanging over the pharmaceutical industry, Switzerland’s Roche announced on Tuesday that it will ...
Roche is committing $50 billion while Regeneron inked a $3 billion manufacturing deal with Fujifilm, allowing the pharma to ...
Wilmington, Del., April 01, 2025 (GLOBE NEWSWIRE) -- Ashland has completed a 10-million-dollar expansion of its pharmaceutical manufacturing plant in Cabreúva, Brazil and will celebrate the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback